Can BPC-157 cause headaches?

This site's BPC-157 studies do not report headache as a counted result. The FDA's 2026 review counted five studies in people with fewer than 110 people in total, and none was built to study headache. No serious side effects were reported in those studies. But they had few people, gave it for two weeks at most, and said little about how safety was checked. The FDA has three side-effect reports about BPC-157 shots: redness and swelling where it was injected, an emergency room visit for shortness of breath, and darkened skin and gums. Headache is not among them. This FAQ does not invent a side-effect rate the studies do not contain.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of healing and recovery peptides. BPC-157, TB-500, GHK-Cu, and the tissue repair family, including what actually has human data.